A Novel Pancreatic Β-Cell Targeting Bispecific-Antibody (BsAb) Can Prevent the Development of Type 1 Diabetes in NOD Mice

Clinical Immunology - United States
doi 10.1016/j.clim.2014.04.014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Reduction of T Cell Receptor Diversity in NOD Mice Prevents Development of Type 1 Diabetes but Not Sjögren’s Syndrome

PLoS ONE
Multidisciplinary
2014English

Lymphocyte-Derived Exosomal MicroRNAs Promote Pancreatic Β Cell Death and May Contribute to Type 1 Diabetes Development

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2019English

Targeting Β-Cell Functions in Therapy for Type 2 Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2011English

Adoptive Transfer of Immunomodulatory M2 Macrophages Prevents Type 1 Diabetes in NOD Mice

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Gene Expression Profiles Define a Key Checkpoint for Type 1 Diabetes in NOD Mice

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

Tandem Bispecific Neutralizing Antibody Eliminates HIV-1 Infection in Humanized Mice

Journal of Clinical Investigation
Medicine
2018English

NOD Mice With High Incidence of Type 1 Diabetes Are Not T Lymphocytopenic.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1988English

Type 1 Diabetes: BTNL2‐Ig Protein Attenuates Type 1 Diabetes in Non‐Obese Diabetic (NOD) Mice (Adv. Healthcare Mater. 9/2019)

Advanced healthcare materials
Biomedical EngineeringBiomaterialsPharmaceutical Science
2019English

Type I and II Interferon Receptors Differentially Regulate Type 1 Diabetes Susceptibility in Male Versus Female NOD Mice

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy